SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain
Science Advances · 2026-07-17 · 12 (29)
DOI: 10.1126/sciadv.aed6825 ↗At a glance
Journal article in Science Advances, published on 2026-07-17. Written by Huijie Huang and 16 co-authors. Institution: Center for Neurologic Diseases, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Major MEDLINE topics: LDL-Receptor Related Proteins, Tauopathies, Up-Regulation, Brain. 119 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (original language)
A role for the trafficking receptor SORLA (Sortilin-related receptor containing LDLR class A repeats) in reducing Aβ levels has been well established; however, relatively little is known with respect to whether and how SORLA can potentially affect tau pathology in vivo. Here, we show that transgenic SORLA up-regulation (SORLA TG) can attenuate pathological effects in aged PS19 (P301S tau) mouse brain, including tau phosphorylation and seeding, ventricle dilation, synapse loss, long-term potentiation (LTP) impairment, and glial hyperactivation. Proteomic analysis indicates attenuation of PS19 profiles in PS19/SORLA TG hippocampus, including pathological changes in synapse-related proteins and key drivers of synaptic dysfunction such as ApoE and C1q. Single-nucleus RNA sequencing analysis reveals suppression of PS19 signatures with SORLA up-regulation and identifies a previously unrecognized involvement of Sema4D-PlexinB1/B2 signaling in glial pathology. In contrast, SORLA deletion exacerbates tau seeding and aggregation, glial hyperactivation, and PlxnB1/B2 induction in PS19 hippocampus. These results indicate that SORLA confers neuroprotection against tau toxicity in the PS19 mouse brain.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Center for Neurologic Diseases, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- Center for Data Sciences, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- Bioinformatics Shared Resource, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- Proteomics Core Facility, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
ORCID profiles: Huijie Huang, Wenqi Yang, Juan C Piña-Crespo, Jay Bhatnagar, Julian Curatolo, Rabi Murad, Alexandra Houser, Rebecca A Porritt, Giau Van Vo, Shengjie Feng, Kevin Y Yip, Timothy Y Huang
Funding
- NIA NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- Sanford Burnham Prebys
- National Institute of Health
Cite
APA
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J. C., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P., Campos, A., Houser, A., Porritt, R. A., Van Vo, G., Xiao, Q., Zhang, T., Feng, S., Yip, K. Y., & Huang, T. Y. (2026). SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain. Science Advances, 12(29). https://doi.org/10.1126/sciadv.aed6825
Vancouver
Huang H, Shi CH, Yang W, Piña-Crespo JC, Bhatnagar J, Curatolo J, et al. SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain. Science Advances. 2026;12(29). doi:10.1126/sciadv.aed6825
BibTeX
@article{Huang2026,
author = {Huang, Huijie and Shi, Christina Huan and Yang, Wenqi and Piña-Crespo, Juan C and Bhatnagar, Jay and Curatolo, Julian and Murad, Rabi and Shah, Palak and Campos, Alex and Houser, Alexandra and Porritt, Rebecca A and Van Vo, Giau and Xiao, Qiang and Zhang, Tongmei and Feng, Shengjie and Yip, Kevin Y and Huang, Timothy Y},
title = {SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {29},
doi = {10.1126/sciadv.aed6825}
}
EUVIMED